Cita APA

Reich, T. R., Switzeny, O. J., Renovanz, M., Sommer, C., Kaina, B., Christmann, M., & Tomicic, M. T. (2017). Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome. Oncotarget.

Chicago Style Citation

Reich, Thomas R., Olivier J. Switzeny, Mirjam Renovanz, Clemens Sommer, Bernd Kaina, Markus Christmann, i Maja T. Tomicic. "Epigenetic Silencing of XAF1 in High-grade Gliomas Is Associated With IDH1 Status and Improved Clinical Outcome." Oncotarget 2017.

Cita MLA

Reich, Thomas R., et al. "Epigenetic Silencing of XAF1 in High-grade Gliomas Is Associated With IDH1 Status and Improved Clinical Outcome." Oncotarget 2017.